The global in-vitro fertilization microscope market size was estimated at USD 109.78 million in 2023 and is projected to reach USD 193.25 million by 2030, growing at a CAGR of 8.45% from 2024 to 2030. The growth of this market is primarily driven by the improving success rates of IVF procedures and the increasing availability of financial assistance, which are expected to encourage greater adoption of assisted reproductive technologies over the forecast period.
In addition, product innovations by manufacturers are contributing to enhanced treatment efficiency and reduced procedure costs, further supporting the uptake of advanced IVF microscope technologies.
In recent years, there have been notable advancements in microscopes and related equipment used in IVF. Researchers have increasingly focused on incorporating artificial intelligence (AI), embryo assessment, and sperm selection technologies to optimize the IVF process. For example, in December 2022, researchers from Weill Cornell Medicine announced the development of STORK-A, an AI algorithm capable of predicting whether an in vitro-fertilized embryo has a normal or abnormal number of chromosomes.
STORK-A achieves an accuracy rate of approximately 70% and utilizes microscope images of embryos captured five days after fertilization, along with a quality score assigned to the embryo by clinic staff, the mother’s age, and other routinely collected IVF data. This non-invasive method has the potential to significantly improve IVF success rates while reducing the need for invasive genetic testing, marking a major step forward in enhancing reproductive outcomes.
Key Market Trends Insights:
• In 2023, Europe dominated the global in-vitro fertilization (IVF) microscope market, accounting for a revenue share of approximately 38%. This leadership can be attributed to the region’s well-established healthcare infrastructure, advanced assisted reproductive technology (ART) facilities, and widespread adoption of innovative IVF procedures.
• Meanwhile, the Asia Pacific region is expected to witness a significant compound annual growth rate (CAGR) over the forecast period. This anticipated growth is driven by factors such as rising infertility rates, increasing awareness of assisted reproductive technologies, expanding healthcare infrastructure, and the growing availability of financial assistance for IVF treatments in emerging economies.
• When analyzed by end-use, the clinical segment led the market in 2023, capturing the largest revenue share of 94%. This indicates that fertility clinics, hospitals, and specialized reproductive health centers remain the primary users of IVF microscopes, leveraging these devices to improve treatment efficiency, enhance embryo assessment, and increase overall success rates of IVF procedures.
Order a free sample PDF of the In-vitro Fertilization Microscopes Market Intelligence Study, published by Grand View Research.
Market Size Forecast:
• 2023 Market Size: USD 109.78 Million
• 2030 Projected Market Size: USD 193.25 Million
• CAGR (2024-2030): 8.45%
• Europe: Largest market in 2023
Key Companies Market Share Insights:
Some of the key players in the global in-vitro fertilization (IVF) microscope market include Leica Microsystems, Olympus Corporation, Zeiss, Nikon Corporation, Euromex Microscopen BV, and Sutter Instrument Company. These companies are recognized for their extensive expertise in microscopy, imaging technologies, and scientific instruments, contributing significantly to advancements in IVF procedures.
Leica Microsystems, a subsidiary of Danaher since 2005, operates under the life sciences and diagnostics segment. The company manufactures a wide range of microscopes and scientific instruments and functions across three main divisions: life sciences, medical, and industrial. Its products are widely used in research, diagnostics, and clinical applications, supporting laboratories and fertility clinics in improving procedural accuracy and efficiency.
Olympus Corporation operates through four primary segments: endoscopic solutions, therapeutic solutions, scientific solutions, and imaging. Its scientific solutions division provides a variety of products, including measurement and imaging instruments, microscopes, videoscopes, and X-ray analyzers. Olympus has a presence in approximately 39 countries, reflecting its global reach in scientific instrumentation and microscopy solutions.
Nikon Corporation is known for manufacturing optical instruments, including optical glasses, imaging products, healthcare products, and industrial metrology products. The company operates through four segments: industrial metrology, healthcare, precision equipment, and imaging products. The microscope solutions unit is a part of its healthcare business division, focusing on improving laboratory diagnostics and research applications.
Sutter Instrument Company specializes in manufacturing research instruments, including microscopes, imaging products, amplifiers, micromanipulators, stages and translators, and perfusion systems. The company distributes its products globally through a network of distributors in approximately 49 countries, spanning North America, Latin America, Europe, Asia, Australia/New Zealand, and the Middle East.
Key Players
• Linkam Scientific Instruments
• Olympus Corporation
• Leica Microsystem (Danaher Corporation)
• Meiji Techno
• Zeiss
• Euromex Microscopen B.V.
• Labomed, Inc.
• Nikon Corporation
• Narishige Group
• Eppendorf AG
• Hamilton Thorne Ltd.
• Sutter Instrument Company
• Tritech Research, Inc.
Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.
Conclusion:
The global in-vitro fertilization (IVF) microscope market is experiencing significant growth, driven by advancements in technology and increasing demand for assisted reproductive technologies. Key factors contributing to this growth include improving success rates of IVF procedures, the growing availability of financial assistance, and product innovations that enhance treatment efficiency and reduce procedure costs. Technological advancements, such as the development of AI algorithms for embryo assessment, are further propelling the adoption of novel technologies in IVF procedures. As the market continues to evolve, it is expected to witness substantial growth over the forecast period.
